These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1026 related items for PubMed ID: 22141388

  • 1. Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
    McCormack PL.
    Drugs; 2011 Dec 24; 71(18):2457-89. PubMed ID: 22141388
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.
    Health Technol Assess; 2008 Apr 24; 12(11):1-278, iii. PubMed ID: 18405470
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib: a review of its use in the management of arthritis and acute pain.
    Frampton JE, Keating GM.
    Drugs; 2007 Apr 24; 67(16):2433-72. PubMed ID: 17983259
    [Abstract] [Full Text] [Related]

  • 4. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis.
    Croom KF, Siddiqui MA.
    Drugs; 2009 Jul 30; 69(11):1513-32. PubMed ID: 19634927
    [Abstract] [Full Text] [Related]

  • 5. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.
    JAMA; 2000 Sep 13; 284(10):1247-55. PubMed ID: 10979111
    [Abstract] [Full Text] [Related]

  • 6. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 13; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 7. Clinical use and pharmacological properties of selective COX-2 inhibitors.
    Shi S, Klotz U.
    Eur J Clin Pharmacol; 2008 Mar 13; 64(3):233-52. PubMed ID: 17999057
    [Abstract] [Full Text] [Related]

  • 8. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC.
    Clin Exp Rheumatol; 2001 Mar 13; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [Abstract] [Full Text] [Related]

  • 9. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC.
    Curr Top Med Chem; 2005 Mar 13; 5(5):443-8. PubMed ID: 15974939
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor.
    Bannwarth B, Berenbaum F.
    Expert Opin Investig Drugs; 2005 Apr 13; 14(4):521-33. PubMed ID: 15882125
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan.
    Sakamoto C, Soen S.
    Digestion; 2011 Apr 13; 83(1-2):108-23. PubMed ID: 21042022
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
    Clemett D, Goa KL.
    Drugs; 2000 Apr 13; 59(4):957-80. PubMed ID: 10804043
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
    Deeks JJ, Smith LA, Bradley MD.
    BMJ; 2002 Sep 21; 325(7365):619. PubMed ID: 12242171
    [Abstract] [Full Text] [Related]

  • 14. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ, Figgitt DP.
    Drugs; 2001 Sep 21; 61(6):833-65. PubMed ID: 11398914
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen.
    De Vecchis R, Baldi C, Di Biase G, Ariano C, Cioppa C, Giasi A, Valente L, Cantatrione S.
    Minerva Cardioangiol; 2014 Dec 21; 62(6):437-48. PubMed ID: 25029569
    [Abstract] [Full Text] [Related]

  • 16. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.
    Moore RA, Derry S, Makinson GT, McQuay HJ.
    Arthritis Res Ther; 2005 Dec 21; 7(3):R644-65. PubMed ID: 15899051
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs.
    Mallen SR, Essex MN, Zhang R.
    Curr Med Res Opin; 2011 Jul 21; 27(7):1359-66. PubMed ID: 21561397
    [Abstract] [Full Text] [Related]

  • 18. Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.
    Kristensen LE, Jakobsen AK, Askling J, Nilsson F, Jacobsson LT.
    Arthritis Care Res (Hoboken); 2015 Aug 21; 67(8):1137-49. PubMed ID: 25623277
    [Abstract] [Full Text] [Related]

  • 19. Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective.
    Bessette L, Risebrough N, Mittmann N, Roussy JP, Ho J, Zlateva G.
    J Med Econ; 2009 Sep 21; 12(3):246-58. PubMed ID: 19743942
    [Abstract] [Full Text] [Related]

  • 20. [Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review].
    Mateos JL.
    Drugs Today (Barc); 2010 Feb 21; 46 Suppl A():1-25. PubMed ID: 20224826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.